Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Allred

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Breast Cancer Research and Treatment|January 1, 1993
Prognostic significance of p53 gene alterations in node-negative breast cancerR M Elledge, S A Fuqua, G M Clark, et al.
Science (New York, N.Y.)|April 5, 1996
Response: Location of BRCA1 in Human Breast and Ovarian Cancer CellsY Chen, P L Chen, D J Riley, et al.
Cancer|April 7, 1998
bcl-2 and apoptosis in lymph node positive breast carcinomaM D Berardo, R M Elledge, C de Moor, et al.
Breast Cancer Research and Treatment|April 16, 1998
Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with responseA Makris, T J Powles, D C Allred, et al.
Cancer|September 15, 1992
Prognosis and treatment decisions in patients with breast cancer without axillary node involvementW L McGuire, A K Tandon, D C Allred, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Treatment decisions in axillary node-negative breast cancer patientsW L McGuire, A K Tandon, D C Allred, et al.
Human Gene Therapy|June 20, 1996
Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancerD Yee, S E McGuire, N Brünner, et al.
Breast Cancer Research and Treatment|August 21, 2001
Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancerJ Zhou, D C Allred, I Avis, et al.
Cancer Research|January 4, 1998
Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancerG M Clark, D C Allred, S G Hilsenbeck, et al.
The Journal of Clinical Investigation|November 1, 1989
Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic miceC L Arteaga, L J Kitten, E B Coronado, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Breast Cancer Research and Treatment|January 1, 1993
Prognostic significance of p53 gene alterations in node-negative breast cancerR M Elledge, S A Fuqua, G M Clark, et al.
Science (New York, N.Y.)|April 5, 1996
Response: Location of BRCA1 in Human Breast and Ovarian Cancer CellsY Chen, P L Chen, D J Riley, et al.
Cancer|April 7, 1998
bcl-2 and apoptosis in lymph node positive breast carcinomaM D Berardo, R M Elledge, C de Moor, et al.
Breast Cancer Research and Treatment|April 16, 1998
Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with responseA Makris, T J Powles, D C Allred, et al.
Cancer|September 15, 1992
Prognosis and treatment decisions in patients with breast cancer without axillary node involvementW L McGuire, A K Tandon, D C Allred, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Treatment decisions in axillary node-negative breast cancer patientsW L McGuire, A K Tandon, D C Allred, et al.
Human Gene Therapy|June 20, 1996
Adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase in an ascites model of human breast cancerD Yee, S E McGuire, N Brünner, et al.
Breast Cancer Research and Treatment|August 21, 2001
Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancerJ Zhou, D C Allred, I Avis, et al.
Cancer Research|January 4, 1998
Mitosin (a new proliferation marker) correlates with clinical outcome in node-negative breast cancerG M Clark, D C Allred, S G Hilsenbeck, et al.
The Journal of Clinical Investigation|November 1, 1989
Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic miceC L Arteaga, L J Kitten, E B Coronado, et al.
Pageof 8